Aims: Acromegaly is a rare disorder resulting from benign growth hormone secreting pituitary adenomas. Many factors affect long-term outcomes in acromegaly. In this study we aimed to investigate effects of hormonal status, morphological subtypes, immunohistochemical expression of pituitary hormones and Ki-67 labeling index on long-term outcomes in patients with acromegaly.
Methods:. We collected the medical and pathological records of sixty-four patients who underwent surgery for growth hormone (GH) secreting somatotroph tumors between 2005-2017.
Results: The remission rate after surgery was 48% (31/64) in all patients (33% for macroadenomas, 94% for microadenomas; p <0.001) with a median follow up of 48 months (12-198). There was no significant relationship between Ki-67 labeling index and remission status (p=0.140). The remission group were significantly older than the nonremission group [47 (21-67) vs 36 (18-56); p=0.012]. We found a statistically significant positive correlation between insulin-like growth factor 1 (IGF-1) levels and Ki-67 labeling index (r=+0.382, p=0.004). Also, there was a significant positive correlation between tumor size and GH (r=+0.368, p=0.027). There was no difference between densely and sparsely granulated adenomas in terms of surgical remission (p=0.866). In multivariate regression analysis, tumor size ≥ 10 mm (macroadenoma) was significant independent variable in predicting remission [95% CI [16.95 (1.92-142)]; p=0.011]. The baseline cortisol levels was correlated negatively with the Ki-67 labeling index (r=+0.293, p=0.02).
Conclusion: The Ki-67 labeling index was not associated with surgical remission in patients with acromegaly. However, the Ki-67 labeling index was higher in younger patients and those with larger adenomas.
Birincil Dil | İngilizce |
---|---|
Konular | Endokrinoloji |
Bölüm | Research Articles |
Yazarlar | |
Erken Görünüm Tarihi | 26 Ekim 2023 |
Yayımlanma Tarihi | 27 Ekim 2023 |
Yayımlandığı Sayı | Yıl 2023 Cilt: 5 Sayı: 4 |
Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]
- Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.
Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamaktadır.
Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/3449/page/10809/update
Dergi Dizin ve Platformları
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.